The Japan Pharmacogenomics Technology Market Size is anticipated to Reach USD 2478.98 Million by 2035, Growing at a CAGR of 7.3% from 2025 to 2035. The Japan pharmacogenomics market growth is due to decreasing sequencing costs, sophisticated bioinformatics, increasing demand for personalized medicine, and an aging population with complex healthcare needs. Government programs and robust academia–industry collaborations also drive technology adoption and clinical integration.